ADAM17 and COVID-19: At the core of COVID-19 pathogenesis lies the dysregulation of signaling and regulation of key proteins including ACE2, IL-17A, TMPRSS2, and ADAM-17, alongside reduced levels of AP and VD, subsequently impacting the progression of inflammatory processes associated with autoimmunity and inflammation modulation [35,36,44].